No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Tuesday, March 24, 2026
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Axis Bank touts quality push, but market flags a host of concerns

by TheAdviserMagazine
8 months ago
in Business
Reading Time: 3 mins read
A A
Axis Bank touts quality push, but market flags a host of concerns
Share on FacebookShare on TwitterShare on LInkedIn


Axis Bank tightened its asset classification and income recognition norms, signalling a more conservative credit approach that appears to have dented the lender’s June-quarter profitability. An unexpected bottom-line shrinkage caused the stock to slump more than 5% Friday, forcing a retreat of the Nifty on which Axis Bank has the third-biggest weighting among private lenders.

“Asset classification happens on a days-past-due (DPD) counter basis, but classification can also occur based on qualitative parameters,” said Puneet Sharma, CFO of Axis Bank, during the post-earnings analyst call. “These are non-DPD-led parameters that have been tightened, resulting in higher slippages for the quarter.”

Sharma explained that under the previous norm, if a borrower with a ₹100 personal loan was five days past due and agreed to a settlement plan, such as three instalments of ₹30 with a one-month moratorium, the account would be upgraded upon payment of the first instalment. Under the new technical norms, such accounts are no longer upgraded until full settlement is made.

The technical impact is largely confined to cash credit, overdraft products, and accounts under one-time settlements (OTS).

This change has adversely affected the bank’s profitability metrics, reducing profit after tax by ₹614 crore, return on assets (ROA) by 15 basis points, and return on equity (ROE) by 1.4 percentage points. One basis point is a hundredth of a percentage point.

Live Events

“The markets expected asset quality issues to be resolved this quarter as this has been a concern over the past year,” said Dharmesh Kant, head of research at Cholamandalam Securities. “Despite the attractive valuations compared to its peers, the guidance for growth is not aggressive, which led to a disappointing quarter.”The stock fell 6.4% during the day and closed 5.3% lower at ₹1,098.7.Kant said that while a further 2-3% decline cannot be ruled out, no major falls are likely since the stock has not performed a lot in the past year either.

Axis bank share chartETMarkets.com

Nifty Heft

Axis Bank has a 2.97% weighting on the Nifty, behind HDFC Bank and ICICI Bank, among lenders. It ranks ninth among the top 10 stocks by weighting on the most-tracked gauge.

Out of the 12 stocks on the Bank Nifty Index, 10 declined and 2 advanced. The Bank Nifty slid 1%, while the benchmark Nifty declined 0.6%.

Meanwhile, Axis Bank’s collections team is now conducting a qualitative assessment of stressed accounts using credit bureau data, particularly by combing those borrowers holding multiple loans.

Gross slippages for the quarter rose more than 70% to ₹8,200 crore, up from ₹4,793 crore in Q1FY25. After adjusting for technical impact, gross slippages stood at ₹5,491 crore. Of this, 75% originated from unsecured loans, while the remaining 25% came from the agriculture sector. 80% of these accounts are backed by 100% security cover.

“These are particularly poor numbers, and the management commentary provided little confidence to expect a quick turnaround in either asset quality or growth,” said Pranav Gundlapalle, head of India financials at Bernstein. “Even after adjusting for the one-off policy changes, Axis Bank’s performance this quarter significantly lags its larger peers, weakening the case for any near-term re-rating.”

Brokerage Nuvama, meanwhile, downgraded Axis Bank to ‘Hold’ and reduced target price to 1,204 from 1,410, citing margin compression and higher credit costs.

“We lower our estimates on credit growth, whereas slightly increase credit cost as asset quality becomes a key monitorable,” said analysts at Nuvama in a note. “For a large banking franchise, the stock is trading at a discount to its peers, which we expect the gap to widen further given volatility in earnings and asset quality.”

To be sure, Bernstein has set a 12-month target price of ₹1,300, while Macquarie Capital expects the stock to reach around ₹1,450.



Source link

Tags: AxisbankConcernsFlagsHostmarketPushQualitytouts
ShareTweetShare
Previous Post

Safe-haven gold gains on global uncertainty, weaker dollar

Next Post

Sebi plans to change MF norms to tackle overlaps, ensure names ‘true-to-label’

Related Posts

edit post
D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

by TheAdviserMagazine
March 24, 2026
0

Mumbai: Indian equities on Tuesday expectedly tracked a pan-Asian rebound in risk assets to climb nearly 2% while the rupee...

edit post
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

by TheAdviserMagazine
March 24, 2026
0

Earnings Call Insights: BioCardia (BCDA) Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final...

edit post
Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)

Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)

by TheAdviserMagazine
March 24, 2026
0

Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock newsEarnings Call Insights:...

edit post
Moldova imposes 60-day energy emergency after Russian strikes in Ukraine

Moldova imposes 60-day energy emergency after Russian strikes in Ukraine

by TheAdviserMagazine
March 24, 2026
0

Moldova’s Parliament voted on Tuesday to impose a state of emergency in the country’s energy sector after Russian strikes on neighboring...

edit post
Private sector growth hits 3.5-year low in March

Private sector growth hits 3.5-year low in March

by TheAdviserMagazine
March 24, 2026
0

New Delhi: India's private sector growth slowed to its weakest pace in more than three-and-a-half years in March as the...

edit post
Smithfield signals .325B–.475B adjusted operating profit target for 2026 while advancing major Sioux Falls investment (NASDAQ:SFD)

Smithfield signals $1.325B–$1.475B adjusted operating profit target for 2026 while advancing major Sioux Falls investment (NASDAQ:SFD)

by TheAdviserMagazine
March 24, 2026
0

Earnings Call Insights: Smithfield Foods (SFD) Q4 2025 Management View Shane Smith, President and CEO, described 2025 as "an outstanding...

Next Post
edit post
Sebi plans to change MF norms to tackle overlaps, ensure names ‘true-to-label’

Sebi plans to change MF norms to tackle overlaps, ensure names ‘true-to-label’

edit post
From Irish whiskey to Italian cheese, U.S. tariffs rattle EU exporters

From Irish whiskey to Italian cheese, U.S. tariffs rattle EU exporters

  • Trending
  • Comments
  • Latest
edit post
Foreclosure Starts are Up 19%—These Counties are Seeing the Highest Distress

Foreclosure Starts are Up 19%—These Counties are Seeing the Highest Distress

February 24, 2026
edit post
7 States Reporting a Surge in Norovirus Cases

7 States Reporting a Surge in Norovirus Cases

February 22, 2026
edit post
Publix to Open 5 New Stores by End of April. See Upcoming Locations.

Publix to Open 5 New Stores by End of April. See Upcoming Locations.

March 20, 2026
edit post
The Growing Movement to End Property Taxes Continues in Kentucky, And What It Means For Investors

The Growing Movement to End Property Taxes Continues in Kentucky, And What It Means For Investors

March 2, 2026
edit post
Who Is Legally Next of Kin in North Carolina?

Who Is Legally Next of Kin in North Carolina?

February 28, 2026
edit post
Georgia’s 0 Tax Rebate Is Moving Forward — Here’s When You Can Expect Your 2026 Check

Georgia’s $250 Tax Rebate Is Moving Forward — Here’s When You Can Expect Your 2026 Check

March 21, 2026
edit post
D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

0
edit post
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

0
edit post
Simply Safe Dividends Review – Is It Worth the Price?

Simply Safe Dividends Review – Is It Worth the Price?

0
edit post
Private sector growth hits 3.5-year low in March

Private sector growth hits 3.5-year low in March

0
edit post
World has ‘never experienced’ refining margins like this

World has ‘never experienced’ refining margins like this

0
edit post
Monthly Dividend Stock In Focus: SmartStop Self Storage REIT

Monthly Dividend Stock In Focus: SmartStop Self Storage REIT

0
edit post
D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

March 24, 2026
edit post
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

March 24, 2026
edit post
Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)

Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)

March 24, 2026
edit post
Shipping Firms Quietly Pay Iran Millions to Navigate Hormuz Corridor – Bitcoin News

Shipping Firms Quietly Pay Iran Millions to Navigate Hormuz Corridor – Bitcoin News

March 24, 2026
edit post
Monthly Dividend Stock In Focus: SmartStop Self Storage REIT

Monthly Dividend Stock In Focus: SmartStop Self Storage REIT

March 24, 2026
edit post
Moldova imposes 60-day energy emergency after Russian strikes in Ukraine

Moldova imposes 60-day energy emergency after Russian strikes in Ukraine

March 24, 2026
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%
  • BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)
  • Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.